ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Is It Time to De-Escalate Radiation Therapy in Patients with HPV+ HNC?

by Karen Appold • November 10, 2019

  • Tweet
  • Email
Print-Friendly Version

Karen Appold is a freelance medical writer based in New Jersey.

You Might Also Like

  • Study: Surgery, Radiation Therapy Equally Effective in Treating OPSCC
  • Primary Radiation vs. Primary Surgical Therapy for Cervical Esophageal Cancer
  • Fanconi Anemia Patients with HNSCC Tolerate Surgery Better than Radiation, Chemotherapy
  • HPV-Positive Oropharnygeal Cancer Has Better Prognosis than Tobacco-Induced Cancer
Explore This Issue
November 2019

How Radiotherapy Works

Radiotherapy works by damaging the DNA in cells. It can potentially kill all cells, but there is increased killing in malignant cells due to the fact that their DNA repair mechanisms often don’t function normally. When cancer cells with a significant DNA injury start to divide, they fall apart and die. “Because cancer cells divide more rapidly than normal cells and aren’t able to repair DNA damage as well, they are more likely to die than normal cells close to the cancer,” said Dr. Ramey.

For head and neck cancers, photons are generated within a machine called a linear accelerator and modulated as they leave the machine with a technique called intensity modulated radiation therapy (IMRT). “As the photon interacts with the patient, its DNA damage is either ignited directly by interacting with the dividing cells or via indirect actions with water within the body,” said David Clump, MD, PhD, assistant professor in the department of radiation oncology, UPMC Hillman Cancer Center, Pittsburgh, Pa. “As the photon interacts with water within the body, the water molecule is split to create a free radical that subsequently damages the DNA of dividing cells.”

The process is optimized by using technology to deliver a quality-assured, reproducible dosing of radiation that aims to minimize toxicity to normal tissues while targeting a tumor and its expected drainage pattern. “Treatments are then delivered over a series of weeks using a specific dose of radiation per treatment as well as a specific number of treatments called fractions,” Dr. Clump said.

Radiotherapy works best on cells in the active replication phase, outside of the G0 (resting) stage of the cell cycle. “As a result, actively replicating cancer cells are the best targets of radiotherapy and tend to respond more quickly,” said Dr. Page. “Normal tissue will exhibit some signs of radiotherapy response sooner or later in a course of therapy, depending on its radiation sensitivity.”

In addition to damaging dividing cells, radiotherapy also works by stimulating an immune response against the tumor. “The interaction of radiation with the immune system is complicated, and radiation can both suppress and enhance anti-tumor immunity depending on how it is delivered and what other treatments the patient receives,” said Dr. Sikora—KA

Pages: 1 2 3 4 | Single Page

Filed Under: Features, Head and Neck, Practice Focus Tagged With: head and neck cancer, HPV, HPV-positive oropharyngeal cancer, radiation therapyIssue: November 2019

You Might Also Like:

  • Study: Surgery, Radiation Therapy Equally Effective in Treating OPSCC
  • Primary Radiation vs. Primary Surgical Therapy for Cervical Esophageal Cancer
  • Fanconi Anemia Patients with HNSCC Tolerate Surgery Better than Radiation, Chemotherapy
  • HPV-Positive Oropharnygeal Cancer Has Better Prognosis than Tobacco-Induced Cancer

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.